Home › NDC Lookup › RxCUI directory › RxCUI 239983

Azathioprine 100 MG Injection — RxCUI 239983

RxNorm drug concept · Semantic clinical drug
RxCUI 239983 Semantic clinical drug · SCD ● Current RxNorm concept 1 FDA product 1 package NDC Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI239983
Official nameAzathioprine 100 MG Injection
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asazathioprine (as azathioprine sodium) 100 MG Injection
FDA products mapped1
Package NDCs mapped1
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Azathioprine: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It helps prevent your body from rejecting a transplanted kidney, and it is also used to reduce the signs and symptoms of active rheumatoid arthritis. It works by calming down the i...
  • The tablets (Imuran, Azasan or generic azathioprine) are taken by mouth, usually once daily, though for rheumatoid arthritis the day's dose may be split in two. Follow your prescri...
  • It usually takes about 6 to 8 weeks, and your doctor will want to give it at least 12 weeks before deciding whether it is helping. Keep taking it as directed in the meantime.
  • How long before it works for my arthritis?
📖 Read our full Azathioprine guide →

🕸️ Concept Web — How Azathioprine 100 MG Injection Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Azathioprine 100 MG Injection RxCUI 239983

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Azathioprine 1256
  2. Dose forms 4

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Azathioprine Injection 1789839
    • Azathioprine Injectable Product 1155000
    • Injection 1649574
    • Injectable Product 1151126
  3. Clinical & branded drugs 1

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Azathioprine 100 MG 360266

Showing up to 8 concepts per family — 6 of 6 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Azathioprine 100 MG SCDC · 360266
  • Azathioprine Injection SCDF · 1789839
  • Azathioprine Injectable Product SCDG · 1155000

📦 FDA Products & Package NDCs

1 product · 1 package NDC
1 package NDC map to RxCUI 239983 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00143-9566-01 1 VIAL in 1 BOX, UNIT-DOSE (0143-9566-01) / 10 mL in 1 VIAL Azathioprine Sodium Hikma Pharmaceuticals USA Inc. 1995-05-01
Observed labelers: Hikma Pharmaceuticals USA Inc. (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.